ABVC BioPharma, Inc. (ABVC) stock
ABVCNasdaqPharmaceutical PreparationsFiscal year ends December 31Also trades as ECOC
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$0.94+0.03 (+3.30%)
Close on Nov 16, 2026Market cap $25.06MP/E –Yield –
ABVC BioPharma gross margin
Gross margin is gross profit as a percentage of revenue.
ABVC BioPharma's gross margin for the twelve months ending Dec 31, 2024 was 171.9%. For fiscal 2024 it was 171.9%, against -98.1% the year before. The highest annual figure on record is 171.9% in fiscal 2024.
Annual gross margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 171.9% | +270.0 |
| FY2023 | Dec 31, 2023 | -98.1% | −168.6 |
| FY2022 | Dec 31, 2022 | 70.5% | −28.1 |
| FY2021 | Dec 31, 2021 | 98.6% | +2.4 |
| FY2020 | Dec 31, 2020 | 96.1% | −1.0 |
| FY2019 | Dec 31, 2019 | 97.1% | – |
Quarterly gross margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q3 FY2025CQ3 2025 | Sep 30, 2025 | 100.0% | +23.0 |
| Q4 FY2024CQ4 2024 | Dec 31, 2024 | 100.0% | +6429.8 |
| Q3 FY2024CQ3 2024 | Sep 30, 2024 | 99.9% | +186.4 |
| Q2 FY2024CQ2 2024 | Jun 30, 2024 | 99.8% | +1194.5 |
| Q1 FY2024CQ1 2024 | Mar 31, 2024 | 77.0% | +24.0 |
| Q4 FY2023CQ4 2023 | Dec 31, 2023 | -6329.8% | −6384.8 |
| Q3 FY2023CQ3 2023 | Sep 30, 2023 | -86.4% | −161.0 |
| Q2 FY2023CQ2 2023 | Jun 30, 2023 | -1094.6% | −1192.0 |
| Q1 FY2023CQ1 2023 | Mar 31, 2023 | 53.0% | −39.6 |
| Q4 FY2022CQ4 2022 | Dec 31, 2022 | 54.9% | −44.7 |
| Q3 FY2022CQ3 2022 | Sep 30, 2022 | 74.6% | −23.4 |
| Q2 FY2022CQ2 2022 | Jun 30, 2022 | 97.3% | −2.2 |
| Q1 FY2022CQ1 2022 | Mar 31, 2022 | 92.6% | −4.3 |
| Q3 FY2021CQ3 2021 | Sep 30, 2021 | 99.6% | +7.1 |
| Q2 FY2021CQ2 2021 | Jun 30, 2021 | 97.9% | −0.2 |
| Q1 FY2021CQ1 2021 | Mar 31, 2021 | 99.5% | +4.6 |
| Q4 FY2020CQ4 2020 | Dec 31, 2020 | 96.9% | −0.6 |
| Q3 FY2020CQ3 2020 | Sep 30, 2020 | 92.5% | −6.0 |
| Q2 FY2020CQ2 2020 | Jun 30, 2020 | 98.1% | +5.1 |
| Q1 FY2020CQ1 2020 | Mar 31, 2020 | 95.0% | −4.3 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | 97.5% | −2.5 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | 98.6% | −1.4 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | 93.0% | – |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | 99.3% | – |
| Q3 FY2017CQ2 2017 | Jun 30, 2017 | 100.0% | – |
| Q1 FY2017CQ4 2016 | Dec 31, 2016 | 100.0% | – |
See a number that looks wrong?